Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fife

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
BMC Cancer|June 6, 2022
Real-world treatment sequencing and survival in previously treated advanced renal cell carcinoma patients receiving nivolumab monotherapy: a UK retrospective cohort studyT Waddell, K Fife, R Griffiths, et al.
Blood|May 1, 1997
Cloning and characterization of exodus, a novel beta-chemokineR Hromas, P W Gray, D Chantry, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 17, 2022
Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient SchemeA Challapalli, S Watkins, G Cogill, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial designE L Gerety, E M Lawrence, J Wason, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)T Powles, J Brown, J Larkin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2017
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialN Basset-Séguin, A Hauschild, R Kunstfeld, et al.
The British Journal of Dermatology|November 5, 2020
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020S G Keohane, J Botting, P G Budny, et al.
The British Journal of Dermatology|May 29, 2021
British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021I Nasr, E J McGrath, C A Harwood, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
BMC Cancer|June 6, 2022
Real-world treatment sequencing and survival in previously treated advanced renal cell carcinoma patients receiving nivolumab monotherapy: a UK retrospective cohort studyT Waddell, K Fife, R Griffiths, et al.
Blood|May 1, 1997
Cloning and characterization of exodus, a novel beta-chemokineR Hromas, P W Gray, D Chantry, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 17, 2022
Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient SchemeA Challapalli, S Watkins, G Cogill, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial designE L Gerety, E M Lawrence, J Wason, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)T Powles, J Brown, J Larkin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2017
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialN Basset-Séguin, A Hauschild, R Kunstfeld, et al.
The British Journal of Dermatology|November 5, 2020
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020S G Keohane, J Botting, P G Budny, et al.
The British Journal of Dermatology|May 29, 2021
British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021I Nasr, E J McGrath, C A Harwood, et al.
Pageof 5